Home / Stocks / IPSC

IPSC insider trading

Century Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
4
Bought · 24 mo
$105k
Buys · last 90 days
0 · $0
Most recent buy
2025-12-29

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-12-29Cowan Chad
Chief Scientific Officer
Bought58,060$0.85$49k
2025-12-16Pfeiffenberger Brent
President and CEO
Bought52,000$0.58$30k
2025-11-20Pfeiffenberger Brent
President and CEO
Bought35,000$0.50$18k
2024-09-16Quimi Daphne
Director
Bought5,000$1.53$8k

Most active insider buyers

InsiderRoleBuysTotal bought
Cowan ChadChief Scientific Officer1$49k
Pfeiffenberger BrentPresident and CEO2$48k
Quimi DaphneDirector1$8k

See IPSC on the chart

Every insider buy and sell for IPSC plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.